PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 111 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2016. The put-call ratio across all filers is 2.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,730,000 | +96.4% | 17,500 | -41.7% | 1.13% | +248.9% |
| Q1 2016 | $881,000 | -55.1% | 30,000 | +20.0% | 0.32% | -49.9% |
| Q4 2015 | $1,960,000 | -66.8% | 25,000 | 0.0% | 0.64% | -74.0% |
| Q1 2015 | $5,903,000 | +211.8% | 25,000 | +150.0% | 2.48% | +171.4% |
| Q4 2014 | $1,893,000 | -20.7% | 10,000 | 0.0% | 0.92% | -28.2% |
| Q3 2014 | $2,386,000 | +31.5% | 10,000 | -63.6% | 1.27% | +50.4% |
| Q2 2014 | $1,815,000 | -50.2% | 27,500 | -21.4% | 0.85% | -49.7% |
| Q1 2014 | $3,645,000 | +40.8% | 35,000 | +40.0% | 1.68% | +14.2% |
| Q4 2013 | $2,588,000 | – | 25,000 | – | 1.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 200,000 | $20,706,000 | 6.01% |
| Redmile Group, LLC | 230,673 | $23,882,000 | 2.95% |
| WEATHERBIE CAPITAL, LLC | 241,419 | $24,994,000 | 2.31% |
| Tekla Capital Management LLC | 185,820 | $19,238,000 | 2.02% |
| Ghost Tree Capital, LLC | 25,000 | $2,588,000 | 1.59% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $588,741,000 | 1.56% |
| Iguana Healthcare Management, LLC | 25,000 | $2,588,000 | 1.48% |
| Eventide Asset Management | 42,100 | $4,359,000 | 1.34% |
| Bain Capital Public Equity Management, LLC | 401,330 | $41,550,000 | 1.17% |
| Rock Springs Capital Management LP | 31,500 | $3,261,000 | 1.16% |